Book cover for Pharmacology and the Nursing Process

Pharmacology and the Nursing Process

Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder

ISBN #9780323087896

7th Edition

394 Questions

Group icon
2,697 Students Helped

Homework Questions

Right arrow
Summary
Learning Objectives
Key Concepts
Example Problems
Explanations
Common Mistakes

Summary

This chapter section on Anemia Drugs focuses on the comprehensive profiles of key drug classes including alpha blockers, beta blockers, and alkylating agents. It emphasizes an in-depth understanding of their pharmacokinetics, clinical applications, contraindications, and adverse effects. The explanation of mechanisms for drugs like phentolamine, tamsulosin, and beta blockers, along with discussions on drug interactions and proper administration, is crucial for materializing safe and effective therapeutic strategies in both cardiovascular and cancer treatment.

Learning Objectives

1

Describe the pharmacokinetics and clinical applications of alpha blockers, beta blockers, and alkylating agents.

2

Explain the mechanisms of action for beta blockers and alkylating antineoplastic agents in managing cardiovascular conditions and cancer.

3

Identify contraindications, potential adverse effects, and drug interactions associated with these drug classes.

4

Understand proper drug administration techniques to minimize complications during therapy.

Key Concepts

CONCEPT

DEFINITION

Alpha Blockers

A class of drugs that inhibit alpha-adrenergic receptors, used for managing cardiovascular conditions and urological issues; examples include phentolamine and tamsulosin.

Phentolamine

An alpha blocker used primarily for cardiovascular indications; it works by dilating blood vessels to reduce blood pressure.

Tamsulosin

An alpha blocker targeted towards urological indications, particularly benign prostatic hyperplasia (BPH), by relaxing smooth muscle in the bladder neck and prostate.

Beta Blockers

Medications that block beta-adrenergic receptors to decrease heart rate and contractility, thereby managing cardiovascular conditions such as hypertension and arrhythmias.

Alkylating Agents

A group of chemotherapeutic drugs that work by adding alkyl groups to DNA, leading to the interruption of cell division and the treatment of various cancers.

Example Problems

Example 1

When administering oral iron tablets, the nurse should keep in mind that the most appropriate substance, other than water, to give with these tablets is a pudding. b an antacid. c milk. d orange juice.

Example 2

The nurse is teaching a patient about oral iron supplements. Which statement is correct? a "You need to take this medication on an empty stomach or else it won't be absorbed." $\mathrm{b}^{\text {" }}$ It is better absorbed on an empty stomach, but if that causes your stomach to be upset, you can take it with food." c "Take this medication with a sip of water, and then lie down to avoid problems with low blood pressure." d "If you have trouble swallowing the tablet, you may crush it."

Example 3

The nurse is administering an intravenous dose of iron dextran. For which potential adverse effect is it most important for the nurse to monitor at this time? a Anaphylaxis b Gastrointestinal distress c Black, tarry stools d Bradycardia

Example 4

The nurse is assessing a patient who is to receive folic acid supplements. It is important to rule out which condition before giving the folic acid? a Malabsorption syndromes b Pernicious anemia c Tropical sprue d Pregnancy

Example 5

A patient with renal failure has severe anemia, and there is an order for darbepoetin (Aranesp). As the nurse assesses the patient, which condition listed will the nurse consider a contraindication to use of this medication? a Uncontrolled hypertension b Diabetes mellitus c Hypothyroidism d Angina
Scroll left
Scroll right

Step-by-Step Explanations

QUESTION

How does phentolamine function as an alpha blocker in cardiovascular therapy?

STEP-BY-STEP ANSWER:

Step 1: Recognize that phentolamine binds to alpha-adrenergic receptors, preventing the binding of natural catecholamines like norepinephrine.
Step 2: This inhibition leads to the relaxation of vascular smooth muscle and subsequent vasodilation.
Step 3: The vasodilation decreases peripheral resistance, reducing blood pressure.
Final Answer: Phentolamine functions by blocking alpha receptors, leading to vasodilation and a decrease in blood pressure.

Mechanism of Phentolamine

QUESTION

What is the step-by-step process by which beta blockers manage cardiovascular conditions?

STEP-BY-STEP ANSWER:

Step 1: Beta blockers attach to beta-adrenergic receptors on the heart, preventing the binding of adrenaline and noradrenaline.
Step 2: This blockade decreases heart rate and contractility.
Step 3: Lower heart rate reduces the oxygen demand of the heart and improves overall cardiovascular stability.
Final Answer: Beta blockers lower heart rate and contractility by blocking beta receptors, contributing to the management of cardiovascular conditions.

Mechanism of Beta Blockers

QUESTION

How do alkylating agents contribute to cancer chemotherapy via their mechanism of action?

STEP-BY-STEP ANSWER:

Step 1: Alkylating agents add alkyl groups to the DNA molecule.
Step 2: This alteration disrupts the DNA structure, inhibiting replication and transcription.
Step 3: As a result, rapidly dividing cancer cells are unable to proliferate, leading to cell death.
Final Answer: Alkylating agents work in chemotherapy by modifying DNA, thereby halting cell division and inducing apoptosis in cancer cells.

Action of Alkylating Agents in Chemotherapy

Scroll left
Scroll right

Common Mistakes

  • Assuming all alpha blockers have identical applications without considering specific drug profiles such as those of phentolamine versus tamsulosin.
  • Overlooking the distinct mechanisms of beta blockers and alkylating agents, leading to incorrect assumptions about their clinical use.
  • Failing to recognize contraindications and potential adverse effects, which can result in improper dosing or drug interactions.
  • Neglecting the importance of proper drug administration protocol, thereby increasing the risk of complications during therapy.